The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients

Kimberley P. Good, Jonathan Rabinowitz, David Whitehorn, Philip D Harvey, Goedele DeSmedt, Lili C. Kopala

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Chronic schizophrenia patients have been sampled for factor analytic studies to identify the factor structure of the Positive and Negative Syndrome Scale (PANSS). Many of these studies have identified a cognitive factor, which may provide useful information about patients for whom formal neuropsychological testing is unavailable. However, the relationship between the clinically rated cognitive factor and performance-based cognitive test scores has not been thoroughly examined, particularly in patients who are early in the course of illness. Objectives: The validity of the PANSS cognitive factor was examined in a sample of antipsychotic naïve, first-episode psychosis patients and the PANSS items that best predicted cognitive functioning were identified. Method: PANSS scores and performance on a battery of cognitive tests from the baseline assessment of a clinical trial of 167 neuroleptic naïve patients with schizophrenia-like illnesses were analyzed. Results: Factor analysis revealed a five-factor model that was consistent with previously described factor models from samples of chronically treated patients. There were modest correlations (less than r=0.44) between the derived cognitive factor and six of the neuropsychological test variables (Wisconsin Card Sorting Test total errors and number of categories correctly sorted, WMS-R immediate and delayed recall scores, Category Fluency total score, and WAIS-R digit symbol). Five PANSS items (P6, N5, N6, G2, and G10) were identified that predicted global cognitive functioning; however, 66% of the variance in cognitive functioning remained unexplained. Conclusions: A PANSS cognitive factor can be identified in first-episode, neuroleptic naïve patients. However, clinical ratings of cognitive deficits lack sensitivity and specificity and thus should not be relied upon fully.

Original languageEnglish
Pages (from-to)11-19
Number of pages9
JournalSchizophrenia Research
Volume68
Issue number1
DOIs
StatePublished - May 1 2004
Externally publishedYes

Fingerprint

Neuropsychological Tests
Psychotic Disorders
Antipsychotic Agents
Schizophrenia
Short-Term Memory
Statistical Factor Analysis
Clinical Trials
Sensitivity and Specificity

Keywords

  • First-episode psychosis
  • Neuropsychological test performance
  • PANSS

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients. / Good, Kimberley P.; Rabinowitz, Jonathan; Whitehorn, David; Harvey, Philip D; DeSmedt, Goedele; Kopala, Lili C.

In: Schizophrenia Research, Vol. 68, No. 1, 01.05.2004, p. 11-19.

Research output: Contribution to journalArticle

Good, Kimberley P. ; Rabinowitz, Jonathan ; Whitehorn, David ; Harvey, Philip D ; DeSmedt, Goedele ; Kopala, Lili C. / The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients. In: Schizophrenia Research. 2004 ; Vol. 68, No. 1. pp. 11-19.
@article{7bf56ed2b4b54c68b8a5153fd9eba7ed,
title = "The relationship of neuropsychological test performance with the PANSS in antipsychotic na{\"i}ve, first-episode psychosis patients",
abstract = "Background: Chronic schizophrenia patients have been sampled for factor analytic studies to identify the factor structure of the Positive and Negative Syndrome Scale (PANSS). Many of these studies have identified a cognitive factor, which may provide useful information about patients for whom formal neuropsychological testing is unavailable. However, the relationship between the clinically rated cognitive factor and performance-based cognitive test scores has not been thoroughly examined, particularly in patients who are early in the course of illness. Objectives: The validity of the PANSS cognitive factor was examined in a sample of antipsychotic na{\"i}ve, first-episode psychosis patients and the PANSS items that best predicted cognitive functioning were identified. Method: PANSS scores and performance on a battery of cognitive tests from the baseline assessment of a clinical trial of 167 neuroleptic na{\"i}ve patients with schizophrenia-like illnesses were analyzed. Results: Factor analysis revealed a five-factor model that was consistent with previously described factor models from samples of chronically treated patients. There were modest correlations (less than r=0.44) between the derived cognitive factor and six of the neuropsychological test variables (Wisconsin Card Sorting Test total errors and number of categories correctly sorted, WMS-R immediate and delayed recall scores, Category Fluency total score, and WAIS-R digit symbol). Five PANSS items (P6, N5, N6, G2, and G10) were identified that predicted global cognitive functioning; however, 66{\%} of the variance in cognitive functioning remained unexplained. Conclusions: A PANSS cognitive factor can be identified in first-episode, neuroleptic na{\"i}ve patients. However, clinical ratings of cognitive deficits lack sensitivity and specificity and thus should not be relied upon fully.",
keywords = "First-episode psychosis, Neuropsychological test performance, PANSS",
author = "Good, {Kimberley P.} and Jonathan Rabinowitz and David Whitehorn and Harvey, {Philip D} and Goedele DeSmedt and Kopala, {Lili C.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1016/j.schres.2003.07.001",
language = "English",
volume = "68",
pages = "11--19",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients

AU - Good, Kimberley P.

AU - Rabinowitz, Jonathan

AU - Whitehorn, David

AU - Harvey, Philip D

AU - DeSmedt, Goedele

AU - Kopala, Lili C.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Background: Chronic schizophrenia patients have been sampled for factor analytic studies to identify the factor structure of the Positive and Negative Syndrome Scale (PANSS). Many of these studies have identified a cognitive factor, which may provide useful information about patients for whom formal neuropsychological testing is unavailable. However, the relationship between the clinically rated cognitive factor and performance-based cognitive test scores has not been thoroughly examined, particularly in patients who are early in the course of illness. Objectives: The validity of the PANSS cognitive factor was examined in a sample of antipsychotic naïve, first-episode psychosis patients and the PANSS items that best predicted cognitive functioning were identified. Method: PANSS scores and performance on a battery of cognitive tests from the baseline assessment of a clinical trial of 167 neuroleptic naïve patients with schizophrenia-like illnesses were analyzed. Results: Factor analysis revealed a five-factor model that was consistent with previously described factor models from samples of chronically treated patients. There were modest correlations (less than r=0.44) between the derived cognitive factor and six of the neuropsychological test variables (Wisconsin Card Sorting Test total errors and number of categories correctly sorted, WMS-R immediate and delayed recall scores, Category Fluency total score, and WAIS-R digit symbol). Five PANSS items (P6, N5, N6, G2, and G10) were identified that predicted global cognitive functioning; however, 66% of the variance in cognitive functioning remained unexplained. Conclusions: A PANSS cognitive factor can be identified in first-episode, neuroleptic naïve patients. However, clinical ratings of cognitive deficits lack sensitivity and specificity and thus should not be relied upon fully.

AB - Background: Chronic schizophrenia patients have been sampled for factor analytic studies to identify the factor structure of the Positive and Negative Syndrome Scale (PANSS). Many of these studies have identified a cognitive factor, which may provide useful information about patients for whom formal neuropsychological testing is unavailable. However, the relationship between the clinically rated cognitive factor and performance-based cognitive test scores has not been thoroughly examined, particularly in patients who are early in the course of illness. Objectives: The validity of the PANSS cognitive factor was examined in a sample of antipsychotic naïve, first-episode psychosis patients and the PANSS items that best predicted cognitive functioning were identified. Method: PANSS scores and performance on a battery of cognitive tests from the baseline assessment of a clinical trial of 167 neuroleptic naïve patients with schizophrenia-like illnesses were analyzed. Results: Factor analysis revealed a five-factor model that was consistent with previously described factor models from samples of chronically treated patients. There were modest correlations (less than r=0.44) between the derived cognitive factor and six of the neuropsychological test variables (Wisconsin Card Sorting Test total errors and number of categories correctly sorted, WMS-R immediate and delayed recall scores, Category Fluency total score, and WAIS-R digit symbol). Five PANSS items (P6, N5, N6, G2, and G10) were identified that predicted global cognitive functioning; however, 66% of the variance in cognitive functioning remained unexplained. Conclusions: A PANSS cognitive factor can be identified in first-episode, neuroleptic naïve patients. However, clinical ratings of cognitive deficits lack sensitivity and specificity and thus should not be relied upon fully.

KW - First-episode psychosis

KW - Neuropsychological test performance

KW - PANSS

UR - http://www.scopus.com/inward/record.url?scp=1642310614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642310614&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2003.07.001

DO - 10.1016/j.schres.2003.07.001

M3 - Article

C2 - 15037335

AN - SCOPUS:1642310614

VL - 68

SP - 11

EP - 19

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1

ER -